SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-18-000029
Filing Date
2018-05-10
Accepted
2018-05-09 19:13:35
Documents
88
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20180331x10q.htm 10-Q 2014995
2 EX-31.1 amph-20180331ex311129f8f.htm EX-31.1 22842
3 EX-31.2 amph-20180331ex312dc23da.htm EX-31.2 22962
4 EX-32.1 amph-20180331ex321e01de3.htm EX-32.1 12320
5 EX-32.2 amph-20180331ex322e3c7e2.htm EX-32.2 12293
  Complete submission text file 0001297184-18-000029.txt   8682356

Data Files

Seq Description Document Type Size
6 EX-101.INS amph-20180331.xml EX-101.INS 2152495
7 EX-101.SCH amph-20180331.xsd EX-101.SCH 62315
8 EX-101.CAL amph-20180331_cal.xml EX-101.CAL 50007
9 EX-101.DEF amph-20180331_def.xml EX-101.DEF 193847
10 EX-101.LAB amph-20180331_lab.xml EX-101.LAB 444577
11 EX-101.PRE amph-20180331_pre.xml EX-101.PRE 387555
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 18820060
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences